These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 17013463)

  • 21. Diagnostic and therapeutic utility of B-type natriuretic peptide in patients with renal insufficiency and decompensated heart failure.
    McCullough PA; Kuncheria J; Mathur VS
    Rev Cardiovasc Med; 2003; 4 Suppl 7():S3-S12. PubMed ID: 14668695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure.
    Fonarow GC; Peacock WF; Phillips CO; Givertz MM; Lopatin M;
    J Am Coll Cardiol; 2007 May; 49(19):1943-50. PubMed ID: 17498579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure.
    Nishii M; Inomata T; Takehana H; Naruke T; Yanagisawa T; Moriguchi M; Takeda S; Izumi T
    J Am Coll Cardiol; 2008 Jun; 51(24):2329-35. PubMed ID: 18549918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical uses of brain natriuretic peptide in diagnosing and managing heart failure.
    Anderson KM
    J Am Acad Nurse Pract; 2008 Jun; 20(6):305-10. PubMed ID: 18588657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Consensus document. Type B natriuretic peptide in the Italian cardiology clinical reality: update of the experience].
    Ital Heart J Suppl; 2003 Oct; 4(10):850-61. PubMed ID: 14664297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease.
    Bruch C; Fischer C; Sindermann J; Stypmann J; Breithardt G; Gradaus R
    Am J Cardiol; 2008 Aug; 102(4):469-74. PubMed ID: 18678308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B-type natriuretic Peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure.
    Valle R; Aspromonte N; Giovinazzo P; Carbonieri E; Chiatto M; di Tano G; Feola M; Milli M; Fontebasso A; Barro S; Bardellotto S; Milani L
    J Card Fail; 2008 Apr; 14(3):219-24. PubMed ID: 18381185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-terminal pro-brain natriuretic peptide testing in the emergency department: beneficial effects on hospitalization, costs, and outcome.
    Rutten JH; Steyerberg EW; Boomsma F; van Saase JL; Deckers JW; Hoogsteden HC; Lindemans J; van den Meiracker AH
    Am Heart J; 2008 Jul; 156(1):71-7. PubMed ID: 18585499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiparametric risk stratification in patients with mild to moderate chronic heart failure.
    Scardovi AB; De Maria R; Coletta C; Aspromonte N; Perna S; Cacciatore G; Parolini M; Ricci R; Ceci V
    J Card Fail; 2007 Aug; 13(6):445-51. PubMed ID: 17675058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B-type natriuretic peptide testing is associated with reduced cost in patients with secondary diagnosis of heart failure.
    Hawkins RC; Chung KN
    Clin Chim Acta; 2007 Feb; 377(1-2):276-8. PubMed ID: 17140557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimization of the use of B-type natriuretic peptide levels for risk stratification at discharge in elderly patients with decompensated heart failure.
    Cournot M; Mourre F; Castel F; Ferrières J; Destrac S
    Am Heart J; 2008 Jun; 155(6):986-91. PubMed ID: 18513508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amino terminal B-type natriuretic peptide, renal function, and prognosis in acute heart failure: a hospital cohort study.
    Pimenta JM; Almeida R; Araújo JP; Azevedo A; Friões F; Rocha-Gonçalves F; Ferreira A; Bettencourt P
    J Card Fail; 2007 May; 13(4):275-80. PubMed ID: 17517347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain natriuretic peptide and optimal management of heart failure.
    Li N; Wang JA
    J Zhejiang Univ Sci B; 2005 Sep; 6(9):877-84. PubMed ID: 16130189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natriuretic peptide testing for heart failure therapy guidance in the inpatient and outpatient setting.
    Green SM; Green JA; Januzzi JL
    Am J Ther; 2009; 16(2):171-7. PubMed ID: 19300043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decrease of plasma N-terminal pro beta-type natriuretic peptide as a predictor of clinical improvement after cardiac resynchronization therapy for heart failure.
    Ding LG; Hua W; Zhang S; Chu JM; Chen KP; Wang Y; Wang FZ; Chen X
    Chin Med J (Engl); 2009 Mar; 122(6):617-21. PubMed ID: 19323922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amino-terminal pro-B-type natriuretic peptides and prognosis in chronic heart failure.
    Masson S; Latini R
    Am J Cardiol; 2008 Feb; 101(3A):56-60. PubMed ID: 18243860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure.
    Gegenhuber A; Struck J; Dieplinger B; Poelz W; Pacher R; Morgenthaler NG; Bergmann A; Haltmayer M; Mueller T
    J Card Fail; 2007 Feb; 13(1):42-9. PubMed ID: 17339002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role for precursor Pro-B type natriuretic peptide in assessing response to therapy and prognosis in patients with decompensated heart failure treated with nesiritide.
    Miller WL; Burnett JC; Hartman KA; Hodge DO; Giuliani I; Minard F; Larue C; Jaffe AS
    Clin Chim Acta; 2009 Aug; 406(1-2):119-23. PubMed ID: 19523938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure.
    Cohen-Solal A; Logeart D; Huang B; Cai D; Nieminen MS; Mebazaa A
    J Am Coll Cardiol; 2009 Jun; 53(25):2343-8. PubMed ID: 19539144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Type B natriuretic peptide. Role in heart failure physiopathology, diagnosis, and prognosis].
    Bettencourt P; Azevedo A
    Rev Port Cardiol; 2004 May; 23 Suppl 2():II95-104. PubMed ID: 15222253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.